Related Experiment Videos
The molecular pathology of amyloid deposition in Alzheimer's disease
R N Martins1, P J Robinson, J O Chleboun
1University Department of Surgery, Repatriation General Hospital, Hollywood, Perth, Western Australia.
Molecular Neurobiology
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.
The journal of prevention of Alzheimer's disease·2024
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.
The journal of prevention of Alzheimer's disease·2024
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's Continuum.
The journal of prevention of Alzheimer's disease·2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force.
The journal of prevention of Alzheimer's disease·2023
Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease.
medRxiv : the preprint server for health sciences·2023
A Conformational Variant of p53 (U-p53AZ) as Blood-Based Biomarker for the Prediction of the Onset of Symptomatic Alzheimer's Disease.
The journal of prevention of Alzheimer's disease·2022
A Live-Cell Imaging System for the Identification of Pro- and Anti-Aggregatory α-Synuclein Modulators.
Molecular neurobiology·2026
Low Dose NeuroD1 Delivery in Mouse TBI Models.
Molecular neurobiology·2026